Bienemann B

Independent researcher, Rio de Janeiro, Brazil.

8 papers · ORCID

ArticlePsilocybin

Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.

Varela YM, de O Tavares VD, Delgado LM +12

Europe PMC2026
ArticleAyahuasca

OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study.

Rodrigues RS, Wießner I, Daldegan-Bueno D +4

Europe PMC2025
ArticlePsilocybin

Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.

Mograbi DC, Rodrigues R, Bienemann B +1

Europe PMC2024
ArticleAyahuasca

A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression.

Cruz L, Bienemann B, Palhano-Fontes F +3

Europe PMC2023
ArticlePsilocybin

Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data.

Bienemann B, Barbosa AR, Cruz LVMD +2

Europe PMC2024
ArticlePsychedelics

Adaptation and latent structure of the Brazilian version of the Ego Dissolution Inventory (EDI-BR): an exploratory study.

Bienemann B, Longo MSC, Ridolfi M +5

Europe PMC2024
ArticlePsilocybin

The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness.

Longo MSC, Bienemann B, Multedo M +3

Europe PMC2023
ArticlePsilocybin

Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.

Bienemann B, Ruschel NS, Campos ML +2

Europe PMC2020